1. Home
  2. OPRX vs ENTA Comparison

OPRX vs ENTA Comparison

Compare OPRX & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPRX
  • ENTA
  • Stock Information
  • Founded
  • OPRX 2006
  • ENTA 1995
  • Country
  • OPRX United States
  • ENTA United States
  • Employees
  • OPRX N/A
  • ENTA N/A
  • Industry
  • OPRX Business Services
  • ENTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • OPRX Consumer Discretionary
  • ENTA Health Care
  • Exchange
  • OPRX Nasdaq
  • ENTA Nasdaq
  • Market Cap
  • OPRX 154.9M
  • ENTA 154.0M
  • IPO Year
  • OPRX N/A
  • ENTA 2013
  • Fundamental
  • Price
  • OPRX $9.91
  • ENTA $5.32
  • Analyst Decision
  • OPRX Buy
  • ENTA Buy
  • Analyst Count
  • OPRX 8
  • ENTA 4
  • Target Price
  • OPRX $9.06
  • ENTA $17.25
  • AVG Volume (30 Days)
  • OPRX 155.8K
  • ENTA 203.1K
  • Earning Date
  • OPRX 05-12-2025
  • ENTA 05-20-2025
  • Dividend Yield
  • OPRX N/A
  • ENTA N/A
  • EPS Growth
  • OPRX N/A
  • ENTA N/A
  • EPS
  • OPRX N/A
  • ENTA N/A
  • Revenue
  • OPRX $92,127,000.00
  • ENTA $66,590,999.00
  • Revenue This Year
  • OPRX $12.12
  • ENTA N/A
  • Revenue Next Year
  • OPRX $10.87
  • ENTA N/A
  • P/E Ratio
  • OPRX N/A
  • ENTA N/A
  • Revenue Growth
  • OPRX 28.81
  • ENTA N/A
  • 52 Week Low
  • OPRX $3.78
  • ENTA $4.09
  • 52 Week High
  • OPRX $14.13
  • ENTA $17.24
  • Technical
  • Relative Strength Index (RSI)
  • OPRX 66.01
  • ENTA 46.28
  • Support Level
  • OPRX $9.12
  • ENTA $5.53
  • Resistance Level
  • OPRX $10.38
  • ENTA $6.23
  • Average True Range (ATR)
  • OPRX 0.65
  • ENTA 0.33
  • MACD
  • OPRX 0.06
  • ENTA 0.00
  • Stochastic Oscillator
  • OPRX 78.79
  • ENTA 28.32

About OPRX OptimizeRx Corporation

OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

Share on Social Networks: